Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0001140361-14-034948

Options or other derivatives

  • Chief Executive Officer acquired 1,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Suzdak Peter David · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2014-09-04 Grant or award : show line 1 in the form Stock Option (right to purchase) +1,000,000 $0.83 2024-09-04 1,000,000 1,000,000 D
Loading xslF345X03/doc1.xml…